|
Volumn 9, Issue 3, 2003, Pages 239-
|
Weapons of mass protection
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DIPHTHERIA VACCINE;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
MALARIA VACCINE;
PERTUSSIS VACCINE;
POLIOMYELITIS VACCINE;
TETANUS TOXOID;
YELLOW FEVER VACCINE;
ASTHMA;
BIOLOGICAL WARFARE;
BUDGET;
CHILD HEALTH CARE;
COST BENEFIT ANALYSIS;
DRUG COST;
DRUG MARKETING;
DRUG RESEARCH;
DRUG UTILIZATION;
EDITORIAL;
FINANCIAL MANAGEMENT;
GOVERNMENT;
HEALTH CARE COST;
HEALTH PROGRAM;
IMMUNIZATION;
INFECTION PREVENTION;
INVESTMENT;
LAW;
MALARIA;
MEDICAL RESEARCH;
PRIORITY JOURNAL;
PROFIT;
PUBLIC HEALTH;
TAX;
TUBERCULOSIS;
UNITED STATES;
BIOLOGICAL WARFARE;
COMMUNICABLE DISEASE CONTROL;
GOVERNMENT PROGRAMS;
HUMANS;
IMMUNIZATION PROGRAMS;
PUBLIC HEALTH;
VACCINES;
HUMAN IMMUNODEFICIENCY VIRUS;
|
EID: 0037352274
PISSN: 10788956
EISSN: None
Source Type: Journal
DOI: 10.1038/nm0303-239 Document Type: Editorial |
Times cited : (1)
|
References (0)
|